LINGO-1 antagonists and uses for treatment of demyelinating disorders
US10435467B2 · kind B2 · utility
0Cited by
132References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2016 |
| Grant date | Oct 8, 2019 |
| Priority date | — |
| Expiry date | Jan 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, compositions and kits comprising an anti-LINGO antibody molecule are described herein useful for detecting and/or treating a CNS demyelinating disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.